Yesterday’s post talked about my recent “plunge” into the world of genetic testing via participation in the Scripps-Navigenics study. A comment by Microsoft HealthVault’s Chief Architect, Sean Nolan addressed one of my questions: Exactly what would be the data type that Navigenics would pass over into one’s HealthVault account? Sean stated that it would be about as rich a data set as possible with importation of the complete SNP files and stored in NCBI dbSNP format.
This got me to thinking last night that the real long-term value of genetic testing may not be in understanding one’s predispositions to specific diseases, though that is what the Scripps study (and Navigenics marketing) is focusing on. Rather, the true value (or at least larger value proposition) may come in a few years time when this rich genetic information is combined with one’s medication regime to develop a more personalized and effective medication protocol.